From: Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans
CHS | Age (YEARS) | M/F | CS (%) | TC | TG | HDL | LDL | SBP | DBP | DM | HT (%) | HL (%) | P |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stroke (24Â h) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LA (n = 10) | 62 ± 7 | 5/5 | 2 (20%) | 4.48 ± 0.71 | 1.53 ± 0.43 | 1.13 ± 0.18 | 2.53 ± 0.58 | 132 ± 12 | 84 ± 13 | 1 (10%) | 2 (20%) | 2 (20%) | 0.12 |
SA (n = 9) | 63 ± 6 | 4/5 | 2 (22%) | 4.32 ± 0.63 | 1.43 ± 0.23 | 1.24 ± 0.16 | 2.42 ± 0.61 | 125 ± 10 | 82 ± 14 | 2 (22%) | 2 (22%) | 1 (11%) | 0.32 |
CEmb (n = 9) | 64 ± 5 | 5/4 | 1 (11%) | 4.18 ± 0.52 | 1.23 ± 0.18 | 1.02 ± 0.12 | 2.43 ± 0.47 | 130 ± 12 | 85 ± 11 | 1 (11%) | 1 (11%) | 1 (11%) | 0.46 |
UDN (n = 10) | 61 ± 6 | 5/5 | 2 (20%) | 4.23 ± 0.34 | 1.36 ± 0.33 | 1.25 ± 0.27 | 2.45 ± 0.45 | 135 ± 13 | 80 ± 13 | 1 (10%) | 2 (20%) | 2 (20%) | 0.78 |
Stroke (1Â W) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LA (n = 11) | 65 ± 6 | 5/6 | 2 (18%) | 4.12 ± 0.25 | 1.54 ± 0.46 | 1.15 ± 0.12 | 2.50 ± 0.35 | 128 ± 14 | 82 ± 10 | 1 (9%) | 2 (18%) | 2 (20%) | 0.98 |
SA (n = 10) | 66 ± 4 | 5/5 | 2 (20%) | 4.16 ± 0.32 | 1.44 ± 0.35 | 1.10 ± 0.17 | 2.43 ± 0.42 | 138 ± 27 | 86 ± 14 | 1 (10%) | 2 (20%) | 1 (10%) | 0.54 |
CEmb (n = 11) | 62 ± 7 | 6/5 | 2 (18%) | 4.31 ± 0.17 | 1.32 ± 0.38 | 1.15 ± 0.14 | 2.46 ± 0.38 | 137 ± 10 | 85 ± 13 | 1 (9%) | 1 (9%) | 1 (9%) | 0.65 |
UDN (n = 10) | 63 ± 7 | 4/6 | 2 (20%) | 4.42 ± 0.54 | 1.42 ± 0.43 | 1.17 ± 0.12 | 2.35 ± 0.36 | 132 ± 15 | 87 ± 11 | 1 (10%) | 1 (10%) | 1 (10%) | 0.98 |
Stroke (4Â W) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LA (n = 10) | 65 ± 5 | 6/4 | 2 (20%) | 4.39 ± 0.47 | 1.55 ± 0.39 | 1.18 ± 0.13 | 2.62 ± 0.56 | 130 ± 12 | 88 ± 10 | 1 (10%) | 2 (20%) | 2 (20%) | 0.82 |
SA (n = 10) | 64 ± 7 | 4/6 | 1 (10%) | 4.36 ± 0.52 | 1.36 ± 0.36 | 1.09 ± 0.13 | 2.43 ± 0.34 | 129 ± 16 | 85 ± 11 | 2 (20%) | 2 (20%) | 1 (10%) | 0.12 |
CEmb (n = 10) | 63 ± 7 | 5/5 | 2 (20%) | 4.26 ± 0.17 | 1.38 ± 0.29 | 1.12 ± 0.17 | 2.43 ± 0.33 | 130 ± 12 | 86 ± 10 | 1 (10%) | 1 (10%) | 1 (10%) | 0.12 |
UDN (n = 10) | 64 ± 6 | 6/4 | 2 (20%) | 4.24 ± 0.43 | 1.42 ± 0.35 | 1.19 ± 0.16 | 2.44 ± 0.44 | 127 ± 13 | 82 ± 12 | 1 (10%) | 2 (20%) | 1 (10%) | 0.34 |
Stroke (24Â W) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LA (n = 10) | 65 ± 7 | 6/4 | 1 (10%) | 4.36 ± 0.27 | 1.56 ± 0.42 | 1.14 ± 0.15 | 2.43 ± 0.56 | 126 ± 15 | 88 ± 12 | 1 (10%) | 2 (20%) | 2 (20%) | 0.87 |
SA (n = 9) | 66 ± 6 | 4/5 | 1 (11%) | 4.39 ± 0.59 | 1.44 ± 0.32 | 1.17 ± 0.12 | 2.39 ± 0.45 | 124 ± 13 | 83 ± 11 | 2 (22%) | 2 (22%) | 1 (11%) | 0.23 |
CEmb (n = 10) | 64 ± 5 | 5/5 | 1 (10%) | 4.35 ± 0.49 | 1.37 ± 0.41 | 1.15 ± 0.16 | 2.50 ± 0.43 | 126 ± 15 | 85 ± 12 | 1 (10%) | 1 (10%) | 1 (10%) | 0.13 |
UDN (n = 9) | 65 ± 6 | 5/4 | 1 (11%) | 429 ± 0.39 | 1.49 ± 0.29 | 1.19 ± 0.18 | 2.45 ± 0.45 | 125 ± 13 | 86 ± 11 | 1 (11%) | 1 (11%) | 1 (11%) | 0.56 |
Stroke (48Â W) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LA (n = 10) | 64 ± 7 | 6/4 | 2 (20%) | 4.46 ± 0.28 | 1.57 ± 0.42 | 1.15 ± 0.13 | 2.55 ± 0.43 | 127 ± 12 | 84 ± 12 | 1 (10%) | 2 (20%) | 2 (20%) | 0.11 |
SA (n = 10) | 66 ± 5 | 5/5 | 2 (20%) | 4.35 ± 0.42 | 1.43 ± 0.32 | 1.17 ± 0.20 | 2.46 ± 0.53 | 123 ± 11 | 83 ± 10 | 2 (20%) | 1 (10%) | 1 (10%) | 0.45 |
CEmb (n = 10) | 65 ± 7 | 4/6 | 1 (10%) | 4.37 ± 0.42 | 1.38 ± 0.41 | 1.23 ± 0.15 | 2.61 ± 0.53 | 125 ± 10 | 87 ± 14 | 1 (10%) | 1 (10%) | 1 (10%) | 0.55 |
UDN (n = 9) | 64 ± 8 | 5/4 | 1 (11%) | 4.44 ± 0.32 | 1.42 ± 0.33 | 1.17 ± 0.18 | 2.65 ± 0.62 | 129 ± 13 | 87 ± 13 | 1 (11%) | 1 (10%) | 1 (10%) | 0.87 |
Healthy outpatient (n = 50) | 64 ± 6 | 24/26 | 10 (20%) | 4.52 ± 0.48 | 1.39 ± 0.40 | 1.15 ± 0.14 | 2.50 ± 0.62 | 125 ± 11 | 82 ± 11 | 5 (10%) | 5 (10%) | 6 (12%) |  |